<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 06 Dec 2009 05:45:51 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Thriving to Diving:  36 Winners Last Year Struggling This Year</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3372292</guid>
      <description><![CDATA[I was looking at a portfolio that I manage and was struck by some of the metrics.&#160; While the account is up over 20% YTD (it is balanced 60/40 Stocks and Bonds), the current median equity return YTD for the 14&#160;stocks in the account is -11%.&#160; Long story short, I have had a lot of turnover this year and have picked up some stocks, especially in the Healthcare sector, that have lagged over the past few months or even quarters.&#160; As always, I disclose these holdings on my website.&#160;       This morning, I decided to look purposefully for stocks that are down this year after having a strong relative year last year.&#160; There are lots of reasons to be out of sync with the market, but sometimes it's just mean reversion at play.&#160; I took the Russell 3000 and found that 22% of the<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3372292>[More...]</a>]]></description>
      <pubDate>Mon, 27 Jul 2009 05:08:59 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACET</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EZPW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MPR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SYNO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3372292</link>
    </item>
    <item>
      <title>Martek Biosciences:  Time To Revisit</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3344166</guid>
      <description><![CDATA[In 2004, when Martek Biosciences (MATK)  was a high-flying growth stock, I had the opportunity to meet with the CFO.&#160; While what they did sounded real interesting, I walked out of that meeting wishing that I worked at a place that could short stocks.&#160; Long story short, the company was way overly optimistic regarding the prospects for continued growth.&#160; Since then, they have been in my almost permanent &quot;penalty box&quot;, but a recent appearance on&#160;a few&#160;of my screens convinced me to spend some time refreshing myself.&#160; I am glad&#160;that I overcame a bias of permanently labeling a company&#160;or management team, and I believe I have uncovered a pretty decent&#160;growth story<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3344166>[More...]</a>]]></description>
      <pubDate>Sun, 12 Jul 2009 17:15:52 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3344166</link>
    </item>
    <item>
      <title>Stocks Of The Day: Green Mountain Coffee Roasters (NasdaqGS: GMCR), Martek Biosciences (NasdaqGS: MATK)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3259275</guid>
      <description><![CDATA[Green Mountain Coffee Roasters Inc. (GMCR) operates in specialty coffee industry in the United States and internationally.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3259275>[More...]</a>]]></description>
      <pubDate>Fri, 05 Jun 2009 15:55:08 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GMCR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WMT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3259275</link>
    </item>
    <item>
      <title>Earnings Review: March 04, 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3091076</guid>
      <description><![CDATA[Late on Wednesday, Allion Healthcare (NASDAQ: ALLI) reported that its fourth quarter net income nearly doubled to $3.065 million or 12 cents a share from $1.069 million or 6 cents a share in the prior year quarter.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3091076>[More...]</a>]]></description>
      <pubDate>Wed, 04 Mar 2009 23:30:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALLI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CWTR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LTXC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SIGM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3091076</link>
    </item>
    <item>
      <title>Earnings Review: December 11, 2008</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2875747</guid>
      <description><![CDATA[Late on Thursday, Esterline Technologies Corp. (NYSE: ESL), an engineered products and systems provider for aerospace and defense applications, reported that its fourth quarter net profit jumped to  $43.88 million or $1.46 a share.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2875747>[More...]</a>]]></description>
      <pubDate>Fri, 12 Dec 2008 06:21:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">APFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ESL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WEDC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2875747</link>
    </item>
    <item>
      <title>Earnings Preview for Dec 8 - 12 - Earnings Preview</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2858865</guid>
      <description><![CDATA[No companies are expected to top expectations. CKE Restaurants, Inc. (CKE) and National Semiconductor Corporation (NSM) could miss estimates.            Just 49 companies have been confirmed to report for the second week of December. Within this group are S&amp;P 500 members AutoZone, Inc. (AZO), Ciena Corporation (CIEN), Costco<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2858865>[More...]</a>]]></description>
      <pubDate>Fri, 05 Dec 2008 19:12:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADCT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BIOD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BLC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CIEN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CKR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EMKR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ESL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FCEL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FNSR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GEF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GIII</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GIL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GMTN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HOFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HRB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ICOC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IDT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ISYS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KFY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KKD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LTRE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MGAM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MTN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NAVI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NCS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NSM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OPTT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OXM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PBY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PLL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">POWL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SAI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SP500</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TIER</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TTC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WEDC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WMCO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2858865</link>
    </item>
    <item>
      <title>Martek Biosciences Corp. - Zacks Elite Stock of the Day</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2618051</guid>
      <description><![CDATA[Martek Biosciences Corp (MATK) is one of the recent additions to the Focus List. The company has recently announced another earnings surprise and analysts continue to raise their estimates for the biotech company.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2618051>[More...]</a>]]></description>
      <pubDate>Tue, 16 Sep 2008 12:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2618051</link>
    </item>
    <item>
      <title>Martek reports surge in Q3 income, expects strong Q4 sales</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2582319</guid>
      <description><![CDATA[Martek Biosciences Corporation (MATK), a developer of omega-3 docosahexaenoic acid (DHA) products, has reported revenues of $88.4 million for the third quarter of 2008, up 14% from $77.8 million in the third quarter of fiscal 2007.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2582319>[More...]</a>]]></description>
      <pubDate>Fri, 05 Sep 2008 07:06:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2582319</link>
    </item>
    <item>
      <title>Profiting From the Mini-Baby Boom</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2541752</guid>
      <description><![CDATA[Posted By Optiondragon for myhappytrading.com, a social networking site made by traders and investors for traders and investors! Come join us for free!<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2541752>[More...]</a>]]></description>
      <pubDate>Mon, 25 Aug 2008 03:25:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CGI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DIS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EML</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GYMB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HRS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PLCE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2541752</link>
    </item>
    <item>
      <title>Martek Bioseciences: Nutritional Value</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2271355</guid>
      <description><![CDATA[&quot;Martek Biosciences (NASDAQ: MATK) is an intriguing company that can trace its roots back to a small division at Martin-Marietta whose goal was to find a way to feed astronauts on a journey to Mars,&quot; notes Nate Pile.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2271355>[More...]</a>]]></description>
      <pubDate>Mon, 09 Jun 2008 13:56:37 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2271355</link>
    </item>
    <item>
      <title>Studies show Alzheimer's must be caught</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3344621</guid>
      <description><![CDATA[Studies show Alzheimer's must be caught<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3344621>[More...]</a>]]></description>
      <pubDate>Mon, 13 Jul 2009 06:18:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3344621</link>
    </item>
    <item>
      <title>Study: Vermont Ranks As One of Top 'Brain-Healthy' States</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3331549</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Jul. 4--BRATTLEBORO -- Vermont ranks fourth in a new index measuring the nation's &quot;brain smarts&quot; based on diet, social well-being and physical and mental health. &lt;/li&gt;&lt;li&gt;The comprehensive state-by-state &quot;life'sDHA&quot; Index of Brain Health, released at the end of June, was completed by Martek Biosciences Corp. based on 21 brain health indicators. &lt;/li&gt;&lt;li&gt;&quot;The results show that the majority of the top 10 ranked states border or are near the Atlantic or Pacific oceans and appear to have an advantage when it comes to brain health,&quot; according to index advisor Dr. Michael Roizen.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3331549>[More...]</a>]]></description>
      <pubDate>Sat, 04 Jul 2009 17:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3331549</link>
    </item>
    <item>
      <title>Martek Biosciences Q1 Net Income Rises</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3095322</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Martek Biosciences, a developer of health and wellness products, has reported a net income of $9.6 million, or $0.29 per diluted share, for the first quarter of fiscal 2009, compared with $8.7 million, or $0.26 per diluted share, for the first quarter of fiscal 2008.&lt;/li&gt;&lt;li&gt;Revenues for the first quarter ended January 31, 2009 were $87.4 million, up 5% from $82.9 million for the first quarter ended January 31, 2008.&lt;/li&gt;&lt;li&gt;Steve Dubin, CEO of Martek Biosciences, said: &quot;Despite the troubling economy, Martek's first quarter results showed both revenue and bottom line growth reflecting the strength of our core infant formula business, growing consumer awareness of the health benefits of DHA beyond infant formula markets and the continued execution of our business plan.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3095322>[More...]</a>]]></description>
      <pubDate>Fri, 06 Mar 2009 05:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3095322</link>
    </item>
    <item>
      <title>Martek Q1 Revenues Up 5%, Expects $87 million in Q2</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3091539</guid>
      <description><![CDATA[Maryland-based fatty acid food products producer Martek Biosciences Corporation has reported revenues of $87.4 million, up 5% for the first quarter of 2009, compared to revenues of $82.9 million for the same period of 2008. Net income was $9.6 million, or $0.29 per diluted share for the first quarter of 2009, compared with net income of $8.7 million, or $0.26 per diluted share for the same period of 2008.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3091539>[More...]</a>]]></description>
      <pubDate>Thu, 05 Mar 2009 04:03:02 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3091539</link>
    </item>
    <item>
      <title>Martek Announces Third Quarter 2009 Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3453909</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;COLUMBIA, Md., Sept. 2  /PRNewswire-FirstCall/ -- Martek Biosciences Corporation  today announced its financial results for the third quarter of fiscal 2009. &lt;/li&gt;&lt;li&gt;Net income was $8.9 million, or $0.27 per diluted share, for the third quarter of fiscal 2009, a 4% decrease compared with $9.3 million, or $0.28 per diluted share, in last year's third quarter.&lt;/li&gt;&lt;li&gt;Commenting on the quarter, Chief Executive Officer Steve Dubin said, &quot;Martek's third quarter 2009 financial results benefited from a 41% quarter over quarter increase in non-infant formula product sales, a 220 basis point gross margin improvement from last year, and our cost control efforts, but, as anticipated and disclosed at the time of our second quarter earnings press release, we were negatively impacted by de-stocking of inventory by certain of our infant formula customers.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3453909>[More...]</a>]]></description>
      <pubDate>Wed, 02 Sep 2009 20:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3453909</link>
    </item>
    <item>
      <title>Martek Announces Third Quarter 2009 Financial Results ; - Record Non-Infant Formula Nutritional Sales of $10.6 Million, Increase of 41% Over Third Quarter of 2008; - Record Quarterly Gross Margin of 43.7%; - Third Quarter Total Revenues and Earnings in Line With Previously Disclosed Guidance; - Fourth Quarter 2009 Revenue Guidance of $87 Million to $92 Million; - Full Fiscal Year 2009 Earnings Guidance of $1.20 to $1.24 Per Share,  Projected Pre-Tax Earnings Growth of  10% to 15% Over Fiscal 2008</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3457011</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;COLUMBIA, Md., Sept. 2 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) today announced its financial results for the third quarter of fiscal 2009. &lt;/li&gt;&lt;li&gt;Net income was $8.9 million, or $0.27 per diluted share, for the third quarter of fiscal 2009, a 4% decrease compared with $9.3 million, or $0.28 per diluted share, in last year's third quarter.&lt;/li&gt;&lt;li&gt;Commenting on the quarter, Chief Executive Officer Steve Dubin said, &quot;Martek's third quarter 2009 financial results benefited from a 41% quarter over quarter increase in non-infant formula product sales, a 220 basis point gross margin improvement from last year, and our cost control efforts, but, as anticipated and disclosed at the time of our second quarter earnings press release, we were negatively impacted by de-stocking of inventory by certain of our infant formula customers.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3457011>[More...]</a>]]></description>
      <pubDate>Wed, 02 Sep 2009 18:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3457011</link>
    </item>
    <item>
      <title>Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3428401</guid>
      <description><![CDATA[Martek Biosciences Corporation announced today that it has entered into a multi-year, sole-source supply agreement with Milk Powder Solutions, based in Australia. Under the terms of the agreement, Martek will serve as Milk Powder Solutions' exclusive supplier for all of its ARA needs for infant formula products in China and Vietnam under the Gold Cow brand name.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3428401>[More...]</a>]]></description>
      <pubDate>Thu, 20 Aug 2009 20:00:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3428401</link>
    </item>
    <item>
      <title>Martek to Announce Third Quarter 2009 Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3425658</guid>
      <description><![CDATA[Martek Biosciences Corporation announced that it intends to release the results of its third quarter of fiscal 2009 on September 2, 2009, at approximately 4:00 p.m. Eastern Time . Following the release, at 4:45 p.m. ET Martek will conduct a conference call to discuss these results with investors. All interested parties may listen to the call live via webcast by visiting Martek's web site at http://investors.martek.com.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3425658>[More...]</a>]]></description>
      <pubDate>Wed, 19 Aug 2009 12:55:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3425658</link>
    </item>
    <item>
      <title>Martek Signs Sole-Source ARA Supply Agreement with Puleva Food S.L.</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3417536</guid>
      <description><![CDATA[Martek Biosciences Corporation announced today that it has entered into a multi-year sole-source supply agreement with Puleva Food for the use of life'sARA in infant formulas produced by Puleva and sold in Spain. Puleva is part of the Ebro-Puleva group, Spain&amp;#39;s largest agro-food business.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3417536>[More...]</a>]]></description>
      <pubDate>Thu, 13 Aug 2009 20:00:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3417536</link>
    </item>
    <item>
      <title>BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels ; Collaboration Assembles Core Capabilities Across Biofuels Value Chain to Develop Biodiesel Production Using Sugar Feedstocks</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3406758</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;COLUMBIA, Md., Aug. 11 /PRNewswire-FirstCall/ -- BP and Martek Biosciences Corporation (Nasdaq: MATK), today announced the signing of a Joint Development Agreement (JDA) to work on the production of microbial oils for biofuels applications. &lt;/li&gt;&lt;li&gt;Under the terms of the multi-year agreement, Martek and BP will work together to establish proof of concept for large-scale, cost effective microbial biodiesel production through fermentation.&lt;/li&gt;&lt;li&gt;&quot;Martek is pleased to partner with BP's Alternative Energy team, to combine our unique algae-based technologies and intellectual property for the creation of sustainable and affordable technology for microbial biofuel production,&quot; said Steve Dubin, Martek CEO.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3406758>[More...]</a>]]></description>
      <pubDate>Tue, 11 Aug 2009 11:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3406758</link>
    </item>
    <item>
      <title>BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3408514</guid>
      <description><![CDATA[BP and Martek Biosciences Corporation , today announced the signing of a Joint Development Agreement to work on the production of microbial oils for biofuels applications. The partnership combines a broad technology platform and operational capabilities to advance the development of a step-change technology for the conversion of sugars into biodiesel.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3408514>[More...]</a>]]></description>
      <pubDate>Tue, 11 Aug 2009 11:26:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3408514</link>
    </item>
    <item>
      <title>Martek to Present at Upcoming Canaccord Adams Conference</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3376586</guid>
      <description><![CDATA[Martek Biosciences Corporation announced today that it will be presenting at the Canaccord Adams 29th Annual Global Growth Conference which is scheduled to take place August 11-13, 2009 at the InterContinental Boston Hotel in Boston, MA. Steve Dubin, Chief Executive Officer, and Peter L. Buzy, Chief Financial Officer, are scheduled to present on Tuesday, August 11, 2009, at 3:00 p.m. Eastern Time.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3376586>[More...]</a>]]></description>
      <pubDate>Tue, 28 Jul 2009 20:01:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3376586</link>
    </item>
    <item>
      <title>EU Committee Approves New Food Applications for Martek's life'sDHA(TM)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3357407</guid>
      <description><![CDATA[DHA omega-3 innovator and maker of the life'sDHA brand of DHA, Martek Biosciences , announced today that it has received a unanimous positive vote from the Standing Committee On The Food Chain and Animal Health of the European Union for additional novel food approval of life'sDHA in Europe.This is a significant action that will provide for new uses of Martek's DHA-rich algal oil in bakery products, cereal bars, and beverages, including milk-based and milk analogue drinks, throughout the 27 Member States of the European Union. This expands the current categories approved in 2003 which include breakfast cereals, spreadable fat and dressings, dairy products and food supplements.There are currently more than 30 food, beverage and supplement products that include life'sDHA available in the EU.'This additional novel food approval will allow Martek to work in even more food and beverage categories and offer European consumers the important benefits of DHA in healthy and convenient products with life'sDHA for brain, eye and heart health.' said Rob Winwood, PhD, Martek's director of scientific affairs in Europe. The July 15, 2009 draft Commission decision will now pass into the formal procedure before anticipated publication in the Official Journal of the European Union in the coming months. DHA omega-3 is a long-chain omega-3 fatty acid that serves as a primary building block for the brain and the eyes and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages benefit from an adequate supply of DHA omega-3 in their diets. Scientific reviews highlight the importance of DHA omega-3 in proper brain and eye development and function, as well as its importance in cardiovascular health. Leading experts around the world have noted that DHA is an important nutrient for health throughout the life cycle. Yet despite its importance, most consumers do not get enough DHA in their diets.Fish are often incorrectly thought to be the only source of DHA omega-3. However, life&amp;#39;sDHA offers a trusted, vegetarian form of DHA that contains no oceanic pollutants or toxins. Fish are sources of DHA because of the DHA-rich microalgae in their food chain; life&amp;#39;sDHA is derived directly from microalgae, a renewable, sustainable source of DHA that does not deplete ocean resources, and is produced entirely in the U.S. in an FDA-inspected facility. Today, life&amp;#39;sDHA is found in numerous foods, beverages and supplements for people of all ages. It is also the only source of DHA used in U.S. infant formula and is included in more than 99 percent of all formulas on the U.S. market, as well as in more than 200 brands of infant formula, nutritional supplements and functional foods sold in over 75 countries worldwide.Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life&amp;#39;sDHA, a sustainable and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula, and supplements, and life&amp;#39;sARA , an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/. For a complete list of life&amp;#39;sDHA products, visit http://www.lifesdha.com/.Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company&amp;#39;s filings with the Securities and Exchange Commission, including, but not limited to, the company&amp;#39;s Form 10-K for the fiscal year ended October 31, 2008 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K. Contact: Kyle Stults<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3357407>[More...]</a>]]></description>
      <pubDate>Fri, 17 Jul 2009 16:15:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3357407</link>
    </item>
    <item>
      <title>Reminder: Martek to Host Investor Conference Call to Discuss Research Presented at the International Conference on Alzheimer's Disease in Vienna, Austria</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3346708</guid>
      <description><![CDATA[Martek Biosciences Corporation will conduct a conference call for investors to discussDHA research recently presented at the International Conference on Alzheimer's Disease. The call will take place July 13, 2009, at approximately 9 a.m. Eastern Time . All interested parties may listen to the call live via webcast by visiting Martek&amp;#39;s web site at http://investors.martek.com.An archived webcast of the conference call will be available on the Martek&amp;#39;s website for thirty days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-633-8284 or 402-977-9140 and entering pass code 214 31512.Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life&amp;#39;sDHA, a sustainable and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula and supplements, and life&amp;#39;sARA , an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/. CONTACT<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3346708>[More...]</a>]]></description>
      <pubDate>Mon, 13 Jul 2009 11:57:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3346708</link>
    </item>
    <item>
      <title>Form  4/A        Pernock David M           For: Sep 17 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3595171</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3595171>[More...]</a>]]></description>
      <pubDate>Sat, 31 Oct 2009 00:41:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3595171</link>
    </item>
    <item>
      <title>Form  4          Pernock David M           For: Sep 17 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3489237</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3489237>[More...]</a>]]></description>
      <pubDate>Thu, 17 Sep 2009 22:43:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3489237</link>
    </item>
    <item>
      <title>Form  3          Pernock David M           For: Sep 16 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3489231</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3489231>[More...]</a>]]></description>
      <pubDate>Thu, 17 Sep 2009 22:38:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3489231</link>
    </item>
    <item>
      <title>Form  4          Fealey Terence            For: Sep 04 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3468780</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3468780>[More...]</a>]]></description>
      <pubDate>Wed, 09 Sep 2009 22:29:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3468780</link>
    </item>
    <item>
      <title>Form  4          MARTEK BIOSCIENCES CORP   For: Jun 05  Filed by: Devine Michael G (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3262005</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3262005>[More...]</a>]]></description>
      <pubDate>Mon, 08 Jun 2009 22:26:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3262005</link>
    </item>
    <item>
      <title>Form  4          ROTBERG EUGENE H          For: Mar 19 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3140969</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3140969>[More...]</a>]]></description>
      <pubDate>Mon, 23 Mar 2009 21:37:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3140969</link>
    </item>
    <item>
      <title>Form  4          MAYER ROBERT H            For: Mar 19 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3140967</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3140967>[More...]</a>]]></description>
      <pubDate>Mon, 23 Mar 2009 21:36:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3140967</link>
    </item>
    <item>
      <title>Form  4          MACMASTER JR DOUGLAS J    For: Mar 19 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3140968</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3140968>[More...]</a>]]></description>
      <pubDate>Mon, 23 Mar 2009 21:36:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3140968</link>
    </item>
    <item>
      <title>Form  4          Nitze Peter A             For: Mar 19 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3140960</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3140960>[More...]</a>]]></description>
      <pubDate>Mon, 23 Mar 2009 21:35:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3140960</link>
    </item>
    <item>
      <title>Form  4          KELLER JEROME C           For: Mar 19 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3140959</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3140959>[More...]</a>]]></description>
      <pubDate>Mon, 23 Mar 2009 21:33:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MATK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3140959</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=MATK" rel="self" type="application/rss+xml" />
  </channel>
</rss>